Inogen (NASDAQ:INGN) & Anteris Technologies Global (NASDAQ:AVR) Head-To-Head Contrast

Anteris Technologies Global (NASDAQ:AVR) and Inogen (NASDAQ:INGN) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, analyst recommendations, dividends, risk, earnings, valuation and institutional ownership.

Earnings and Valuation

This table compares Anteris Technologies Global and Inogen”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Anteris Technologies Global	N/A	N/A	N/A	N/A	N/A
Inogen	$315.66 million	0.95	-$102.45 million	($2.25)	-5.57

Anteris Technologies Global has higher earnings, but lower revenue than Inogen.

Analyst Ratings

This is a breakdown of recent ratings and target prices for Anteris Technologies Global and Inogen, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Anteris Technologies Global	0	0	4	0	3.00
Inogen	0	2	1	0	2.33

Anteris Technologies Global presently has a consensus target price of $16.50, suggesting a potential upside of 177.31%. Inogen has a consensus target price of $7.00, suggesting a potential downside of 44.13%. Given Anteris Technologies Global’s stronger consensus rating and higher probable upside, equities research analysts clearly believe Anteris Technologies Global is more favorable than Inogen.

Profitability

This table compares Anteris Technologies Global and Inogen’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Anteris Technologies Global	N/A	N/A	N/A
Inogen	-15.89%	-27.38%	-16.77%

Insider & Institutional Ownership

89.9% of Inogen shares are held by institutional investors. 1.0% of Inogen shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Summary

Anteris Technologies Global beats Inogen on 6 of the 9 factors compared between the two stocks.

About Anteris Technologies Global

Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.

About Inogen

Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Simeox airway clearance; batteries; and related accessories. It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.